The final, formatted version of the article will be published soon.
ORIGINAL RESEARCH article
Front. Med.
Sec. Precision Medicine
Volume 11 - 2024 |
doi: 10.3389/fmed.2024.1425414
This article is part of the Research Topic Dyslipidemia, Prevention in the Era of Personalized Medicine? View all 3 articles
Analyzing Lipid Profiles and Dyslipidemia Prevalence in Hypertensive Patients: A Cross-sectional Study from Primary Community Health Institutions
Provisionally accepted- 1 School of Public Health, Shantou University, Shantou, China
- 2 Shenzhen Center for Chronic Disease Control, Shenzhen, China
Background: A significant proportion of hypertensive patients also suffer from comorbid dyslipidemia, which critically influences their treatment outcomes and overall prognosis. Given its implications, the lipid profiles of hypertensive individuals warrant increased attention for more effective clinical management. Methods: We analyzed data from 92,443 hypertensive patients registered at primary community health institutions in 2021. Employing a cross-sectional study design, we assessed the distribution of lipid levels and the prevalence of various dyslipidemia subtypes. Stepwise forward logistic regression was used to identify factors associated with dyslipidemia, adjusting for gender, age, body size, and other relevant characteristics. Results: According to the 2023 Chinese Guidelines for the Management of Lipids, the overall prevalence of dyslipidemia was 37.5%. Subtype analysis revealed prevalence of high total cholesterol (TC) at 11.2%, high triglycerides (TG) at 16.0%, low high-density lipoprotein cholesterol (HDL-C) at 16.0%, and high low-density lipoprotein cholesterol (LDL-C) at 10.2%. TG abnormalities were more common among males (16.8%), whereas TC abnormalities predominated in females (14.4%). Notably, hypertensive patients with diabetes had higher levels of TG compared to non-diabetics (P=0.009). Those with stroke and liver disease comorbidities exhibited lower TG levels than their counterparts (P=0.018 and P<0.001, respectively). Additionally, HDL-C levels were significantly lower in hypertensives with diabetes, coronary artery disease, and central obesity (P<0.001, P=0.026, P<0.001, respectively). Regression analysis indicated that dyslipidemia prevalence correlates significantly with gender, age, diabetes, coronary heart disease, stroke, family history of hypertension, body mass index (BMI), central obesity, frequency of physical activity, smoking status, regular alcohol consumption, and abdominal ultrasound findings. Conclusions: Our study underscores the necessity of rigorous lipid monitoring and analysis of dyslipidemia-influencing factors for the development of effective health management strategies within the community. There
Keywords: Dyslipidemia, Epidemiology, Lipid level, Prevalence, Dyslipidemia component, Associated factors
Received: 14 May 2024; Accepted: 15 Oct 2024.
Copyright: © 2024 Wang, Li, Lv, Wu, Xie, Xie, Wang and Zhao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Zhiguang Zhao, Shenzhen Center for Chronic Disease Control, Shenzhen, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.